Patents by Inventor Joanita Monteiro

Joanita Monteiro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160201130
    Abstract: Describe herein is a novel CATT-tetranucleotide repeat polymorphism at position ?817 of the human Mif gene that functionally affects the activity of the Macrophage Inhibitory Factor (MIF) promoter in gene reporter assays. Four genotypes are described which comprise 5, 6, 7, or 8-CATT repeat units. Of these, the 5-CATT allele has the lowest level of basal and stimulated MIF promoter activity in vitro. The presence of the low expressing, 5-CATT repeat allele correlated with low disease severity in a cohort of rheumatoid arthritis patients. Methods, compositions and apparatus for detecting this CATT-tetranucleotide repeat polymorphism at position ?817 of the human Mif gene, and for using same for assessing predisposition to severe inflammatory disease, are also disclosed.
    Type: Application
    Filed: August 17, 2015
    Publication date: July 14, 2016
    Inventors: John A. Baugh, Richard J. Bucala, Smita Chitnis, Seamus C. Donnelly, Peter K. Gregersen, Joanita Monteiro
  • Patent number: 9139877
    Abstract: Describe herein is a novel CATT-tetranucleotide repeat polymorphism at position ?817 of the human Mif that functionally affects the activity of the Macrophage Inhibitory Factor (MIF) promoter in gene reporter assays. Four genotypes are described which comprise 5, 6, 7, or 8-CATT repeat units. Of these, the 5-CATT allele has the lowest level of basal and stimulated MIF promoter activity in vitro. The presence of the low expressing, 5-CATT repeat allele correlated with low disease severity in a cohort of rheumatoid arthritis patients. Methods, compositions and apparatus for detecting this CATT-tetranucleotide repeat polymorphism at position ?817 of the human Mif gene, and for using same for assessing predisposition to severe inflammatory disease, are also disclosed.
    Type: Grant
    Filed: December 6, 2012
    Date of Patent: September 22, 2015
    Assignees: Baxalta Incorporated, Baxalta GmbH
    Inventors: John A. Baugh, Richard J. Bucala, Smita Chitnis, Seamus C. Donnelly, Peter K. Gregersen, Joanita Monteiro
  • Patent number: 7205107
    Abstract: Describe herein is a CATT-tetranucleotide repeat polymorphism at position ?817 of the human Mif gene that functionally affects the activity of the Macrophage Inhibitory Factor (MIF) promoter in gene reporter assays. Four genotypes are described which comprise 5, 6, 7, or 8-CATT repeat units. Of these, the 5-CATT allele has the lowest level of basal and stimulated MIF promoter activity in vitro. The presence of the low expressing, 5-CATT repeat allele correlated with low disease severity in a cohort of rheumatoid arthritis patients. Methods, compositions and apparatus for detecting this CATT-tetranucleotide repeat polymorphism at position ?817 of the human Mif gene, and for using same for assessing predisposition to severe inflammatory disease, are also disclosed.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: April 17, 2007
    Assignee: Cytokine Pharmasciences, Inc.
    Inventors: John A. Baugh, Richard Bucala, Smita Chitnis, Seamus C. Donnelly, Peter K. Gregersen, Joanita Monteiro
  • Publication number: 20030215446
    Abstract: Describe herein is a novel CATT-tetranucleotide repeat polymorphism at position −817 of the human Mif gene that functionally affects the activity of the Macrophage Inhibitory Factor (MIF) promoter in gene reporter assays. Four genotypes are described which comprise 5, 6, 7, or 8-CATT repeat units. Of these, the 5-CATT allele has the lowest level of basal and stimulated MIF promoter activity in vitro. The presence of the low expressing, 5-CATT repeat allele correlated with low disease severity in a cohort of rheumatoid arthritis patients. Methods, compositions and apparatus for detecting this CATT-tetranucleotide repeat polymorphism at position −817 of the human Mif gene, and for using same for assessing predisposition to severe inflammatory disease, are also disclosed.
    Type: Application
    Filed: December 20, 2002
    Publication date: November 20, 2003
    Inventors: John A. Baugh, Richard Bucala, Smita Chitnis, Seamus C. Donnelly, Peter K. Gregersen, Joanita Monteiro